TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19706214

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 74

Group type: COMPARATOR
Intervention: Mediterranean diet
Number of subjects: 74

Group type: COMPARATOR
Intervention: Low-carbohydrate diet
Number of subjects: 74

Group type: COMPARATOR
Intervention: Mediterranean + Low-carbohydrate (combined)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Support sessions participation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Low-carbohydrate group
Number of subjects: 74
Study: 17242083

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Intranasal midazolam
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 67

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 67
Study: 15260182

Group type: EXPERIMENTAL
Intervention: Biofeedback with real-time spectrum analysis
Number of subjects: 12

Group type: COMPARATOR
Intervention: Traditional voice training
Number of subjects: 12
Study: 11576093

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ondansetron 0.15 mg x kg(‐1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 9818732

Group type: EXPERIMENTAL
Intervention: Wisconsin Card Sorting Test (WCST)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Resting SPECT
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Order effect
Number of subjects: 13
Study: 7711149

Group type: EXPERIMENTAL
Intervention: Enteral nutrition guideline involving a commercialized enteral diet administered in 6 sessions at three-hour intervals, starting with 100 cc per session up to a total of 400 cc (2400 kcal/day) with 100 cc of water added.
Number of subjects: 50
Study: 2523656

Group type: EXPERIMENTAL
Intervention: Isradipine 5 to 20 mg twice daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Atenolol 50 to 100 mg once daily
Number of subjects: 28
Study: 826948

Group type: EXPERIMENTAL
Intervention: Nootropyl (Piracetam) 400 mg per day for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (not explicitly mentioned but implied as control in a double blind study)
Number of subjects: 0
Study: 30206572

Group type: EXPERIMENTAL
Intervention: High-viscosity glass ionomer (Hv-GIC) restorations (Equia, GC)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Nanohybrid composite restorations (E&Ra/nanoC) with a three-step etch-and-rinse adhesive (Optibond FL, Kerr)
Number of subjects: 134
Study: 26975498

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula oxygen therapy
Number of subjects: 527

Group type: COMPARATOR
Intervention: Conventional oxygen therapy
Number of subjects: 527
Study: 24714403

Group type: COMPARATOR
Intervention: Electromagnetic targeting (Sureshot)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Free-hand technique using fluoroscopy
Number of subjects: 99
Study: 23709457

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Hegu (LI4) for 20 min using TENS acupuncture pen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no acupuncture)
Number of subjects: 0
Study: 20632888

Group type: EXPERIMENTAL
Intervention: 5-microg whole-virion aluminum formulation
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: 30-microg split-virion nonaluminum formulation
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: 15-microg split-virion formulation
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: All formulations
Number of subjects: 706
Study: 18257142

Group type: EXPERIMENTAL
Intervention: Hormone Therapy (HT)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351

Group type: COMPARATOR
Intervention: Black cohosh and multibotanical herbs
Number of subjects: 351
Study: 14687955

Group type: EXPERIMENTAL
Intervention: Single subcutaneous depot injection of 58 mg buprenorphine
Number of subjects: 5
Study: 11949771

Group type: EXPERIMENTAL
Intervention: Tryptophan-depleted drink
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Flumazenil (pharmacological challenge)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control drink
Number of subjects: 14
Study: 9541518

Group type: EXPERIMENTAL
Intervention: Progressive high-impact exercise three times a week for 18 months (n=35)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nonexercising controls (n=45)
Number of subjects: 80
Study: 7534716

Group type: EXPERIMENTAL
Intervention: High-dose melphalan (HDM) with autologous bone marrow rescue (ABMR)
Number of subjects: 29

Group type: COMPARATOR
Intervention: High-dose melphalan (HDM) without autologous bone marrow rescue (ABMR)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Recombinant human granulocyte colony-stimulating factor (rhG-CSF) with autograft
Number of subjects: 29

Group type: COMPARATOR
Intervention: High-dose melphalan (HDM)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Recombinant interleukin-4 (rIL-4) in vitro
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Recombinant human granulocyte colony-stimulating factor (rhG-CSF)
Number of subjects: 29
Study: 2502935

Group type: EXPERIMENTAL
Intervention: Clonidine (5 micrograms/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 961724

Group type: EXPERIMENTAL
Intervention: blocking plus instructions
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: blocking plus labels
Number of subjects: 24

Group type: COMPARATOR
Intervention: blocking
Number of subjects: 24
Study: 31703653

Group type: EXPERIMENTAL
Intervention: Positive lifestyle behaviours (exercise for weight reduction)
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Positive lifestyle behaviours (lowered food intake)
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Positive lifestyle behaviours (added vegetables to diet)
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: High birth weight (BW ≥ 3500 g)
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Children with both parents having OW/OB
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Children with one parent having OW/OB
Number of subjects: 821

Group type: COMPARATOR
Intervention: Children with normal-weight parents
Number of subjects: 821
Study: 27068368

Group type: EXPERIMENTAL
Intervention: Group-based outpatient physiotherapy (six group-based exercise sessions after surgery)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual care (standard postoperative care)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Group-based outpatient physiotherapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Recruitment
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Withdrawal
Number of subjects: 46
Study: 25961283

Group type: EXPERIMENTAL
Intervention: F4/AS01E or F4/AS01B followed by Ad35-GRIN
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Ad35-GRIN followed by two doses of F4/AS01B
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Three co-administrations of Ad35-GRIN and F4/AS01B
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: F4/AS01
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Ad35-GRIN
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Co-administration of an adjuvanted protein and an adenovirus vector
Number of subjects: 146
Study: 23370859

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BR)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Nitrate-depleted placebo juice (PL)
Number of subjects: 14
Study: 21596327

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stents (ZES)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 436
Study: 19022642

Group type: EXPERIMENTAL
Intervention: Tiotropium 5 microg via Respimat SMI
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Tiotropium 10 microg via Respimat SMI
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg via HandiHaler
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study: 16420273

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) applied on the mucosa buccally, distally and palatally to the canine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo treatment (pseudo-application)
Number of subjects: 12
Study: 15452472

Group type: EXPERIMENTAL
Intervention: Agitated saline
Number of subjects: 34

Group type: COMPARATOR
Intervention: Oxypolygelatine (OXY)
Number of subjects: 34
Study: 11469844

Group type: EXPERIMENTAL
Intervention: Preoperative administration of ampiroxicam
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study: 9394367

Group type: EXPERIMENTAL
Intervention: Anastrozole (Arimidex)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (general)
Number of subjects: 0
Study: 7696598

Group type: EXPERIMENTAL
Intervention: Deviant tones presented to patients with Alzheimer's disease (AD)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Deviant tones presented to healthy older subjects (control group)
Number of subjects: 19
Study: 3312372

Group type: COMPARATOR
Intervention: Monosodium L-glutamate (MSG) 500 mg capsules, increasing doses from 0.5 gm to 5.0 gm
Number of subjects: 32
Study: 30107833

Group type: EXPERIMENTAL
Intervention: Vaginal washing
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Vaginal lubrication
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Living in Tijuana
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Being born in the same state as the study site
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Monthly income ≥3500 pesos
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Hazardous alcohol consumption
Number of subjects: 295
Study: 27895844

Group type: EXPERIMENTAL
Intervention: Two doses of live, oral rotavirus vaccine
Number of subjects: 4939

Group type: EXPERIMENTAL
Intervention: Three doses of live, oral rotavirus vaccine
Number of subjects: 4939

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4939

Group type: EXPERIMENTAL
Intervention: Pooled vaccine group (two or three doses of vaccine)
Number of subjects: 4939

Group type: EXPERIMENTAL
Intervention: Pooled vaccine group
Number of subjects: 4939
Study: 24215217

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TENS)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (sham stimulation)
Number of subjects: 65
Study: 22372517

Group type: EXPERIMENTAL
Intervention: Diclofenac-K 25 mg liquid capsules
Number of subjects: 132

Group type: COMPARATOR
Intervention: Diclofenac-K 12.5 mg tablets
Number of subjects: 132

Group type: COMPARATOR
Intervention: Ibuprofen 200 mg liquid capsules
Number of subjects: 132

Group type: COMPARATOR
Intervention: ASA 500 mg tablets
Number of subjects: 132
Study: 20541301

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1,200 mg orally, 4 doses at 12-hour intervals
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 60
Study: 18164324

Group type: EXPERIMENTAL
Intervention: Team training intervention (multiphasic staff training program over 6 months)
Number of subjects: 487

Group type: COMPARATOR
Intervention: Control group (site-specific team performance profiles with recommendations)
Number of subjects: 487
Study: 15565899

Group type: EXPERIMENTAL
Intervention: Topical mupirocin treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tight perioperative glycemic control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunonutrition (enteral formulas enriched with arginine, omega‐3 fatty acids, glutamine, and RNA)
Number of subjects: 0
Study: 11281512

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 9395900

Group type: EXPERIMENTAL
Intervention: Allogeneic blood cell transplantation (alloBCT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Allogeneic bone marrow transplantation (alloBMT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Autologous blood cell transplantation (autoBCT)
Number of subjects: 33
Study: 7892705

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (Fansidar)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Amodiaquine
Number of subjects: 100
Study: 3117488

Group type: EXPERIMENTAL
Intervention: Gynovlar (3000 micrograms norethisterone and 50 micrograms ethinyl estradiol)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ovral (250 micrograms levonorgestrel and 50 micrograms ethinyl estradiol)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Minipill (30 micrograms levonorgestrel only)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gynovlar
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ovral
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Minipill
Number of subjects: 40
Study: 31161606

Group type: COMPARATOR
Intervention: Multicomponent educational intervention for parents and adolescents (P + A)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Educational intervention for parents only (P only)
Number of subjects: 11
Study: 30591656

Group type: EXPERIMENTAL
Intervention: Preventive Zinc (PZ) tablets (7 mg/day)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Therapeutic Zinc (TZ) supplements for diarrhea treatment (20 mg/day for 10 days)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Multiple Micronutrient Powder (MNP) sachets (10 mg zinc and 14 other micronutrients)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 512
Study: 27574788

Group type: EXPERIMENTAL
Intervention: AZD5069 5 mg
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: AZD5069 15 mg
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: AZD5069 45 mg
Number of subjects: 640

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 640
Study: 25201763

Group type: EXPERIMENTAL
Intervention: Frequent skin care (oil bath (0.5 dl) and facial fat cream)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Observation group (no intervention)
Number of subjects: 56
Study: 22349085

Group type: EXPERIMENTAL
Intervention: 4 mg/kg caffeine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 19200991

Group type: EXPERIMENTAL
Intervention: 75 IU of rLH daily for 4 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: 150 IU of rFSH for the first 5 days at suppression
Number of subjects: 0
Study: 17341571

Group type: EXPERIMENTAL
Intervention: Gastric loads of 0, 300, 700 kcal infused by nasogastric tube
Number of subjects: 15
Study: 15849701

Group type: EXPERIMENTAL
Intervention: Treatment for hookworm and schistosomiasis in the Intervention group
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (untreated children)
Number of subjects: 600
Study: 11762611

Group type: EXPERIMENTAL
Intervention: Dapsone 100 mg daily
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Rechallenge with Dapsone after withdrawal
Number of subjects: 8
Study: 8996151

Group type: EXPERIMENTAL
Intervention: ECF regimen (epirubicin, cisplatin, and protracted venous infusion fluorouracil)
Number of subjects: 274

Group type: COMPARATOR
Intervention: FAMTX regimen (fluorouracil, doxorubicin, and methotrexate)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: ECF regimen
Number of subjects: 274

Group type: COMPARATOR
Intervention: FAMTX regimen
Number of subjects: 274
Study: 8430924

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP) 300 micrograms daily
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 22
Study: 3690961

Group type: EXPERIMENTAL
Intervention: Narrow section computed tomography
Number of subjects: 10

Group type: COMPARATOR
Intervention: Plain chest radiography
Number of subjects: 10
Study: 31997481

Group type: EXPERIMENTAL
Intervention: 25G atraumatic needle
Number of subjects: 952

Group type: COMPARATOR
Intervention: Stylet reinsertion before needle withdrawal
Number of subjects: 952
Study: 30982547

Group type: EXPERIMENTAL
Intervention: BGF MDI 160/14.4/10 μg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: BGF MDI 320/14.4/10 μg
Number of subjects: 96

Group type: COMPARATOR
Intervention: GFF MDI 14.4/10 μg
Number of subjects: 96
Study: 28552090

Group type: EXPERIMENTAL
Intervention: Deep NMB with 8 mmHg pneumoperitoneum
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard NMB with 12 mmHg pneumoperitoneum
Number of subjects: 110
Study: 26497730

Group type: EXPERIMENTAL
Intervention: Peer mentoring intervention
Number of subjects: 30
Study: 23088232

Group type: EXPERIMENTAL
Intervention: Role model interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self‐affirmation interventions
Number of subjects: 0
Study: 21333879

Group type: EXPERIMENTAL
Intervention: LASIK without iris registration
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: LASIK with static iris registration
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: LASIK with dynamic iris registration
Number of subjects: 3
Study: 17964295

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory therapy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Healthy children (control group)
Number of subjects: 19
Study: 17040176

Group type: EXPERIMENTAL
Intervention: Supportive group therapy
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Interpretive group therapy
Number of subjects: 72
Study: 12751039

Group type: EXPERIMENTAL
Intervention: Preemptive oral ganciclovir therapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 10931518

Group type: EXPERIMENTAL
Intervention: Antidepressant therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cramer-von Mises statistic
Number of subjects: 0
Study: 9056049

Group type: EXPERIMENTAL
Intervention: Activated charcoal administered immediately after amlodipine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Activated charcoal administered 2 hours after amlodipine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Activated charcoal administered 6 hours after amlodipine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (amlodipine ingested with 300 ml of water only)
Number of subjects: 32
Study: 8877209

Group type: EXPERIMENTAL
Intervention: Day-case adenoidectomy
Number of subjects: 429

Group type: COMPARATOR
Intervention: Adenoidectomy (in combination with other minor procedures)
Number of subjects: 429
Study: 29338322

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindfulness (dispositional)
Number of subjects: 0
Study: 29626287

Group type: EXPERIMENTAL
Intervention: Pitavastatin (group P)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 50
Study: 27227692

Group type: EXPERIMENTAL
Intervention: Pain Coping Skills Training (cognitive behavioral therapy)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Pain Coping Skills Training
Number of subjects: 256
Study: 24497963

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/d added to interferon beta-1b (IFNB-1b)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Interferon beta-1b (IFNB-1b) monotherapy
Number of subjects: 77
Study: 21733267

Group type: EXPERIMENTAL
Intervention: Fat-free mass (FFM)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Fat mass (FM)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 92
Study: 20974611

Group type: COMPARATOR
Intervention: Osmophobia prevalence in migraine patients (34.6%) vs tension-type headache patients (14.3%)
Number of subjects: 1020

Group type: EXPERIMENTAL
Intervention: New diagnostic criteria for migraine without aura (MO) based on osmophobia
Number of subjects: 1020
Study: 18677677

Group type: EXPERIMENTAL
Intervention: Interactive e‐Learning
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Virtual lecture (slides and audio)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard lecture (control group; 90 minutes)
Number of subjects: 104
Study: 15997965

Group type: EXPERIMENTAL
Intervention: Professional Care Series (PCS) toothbrush
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sonicare Elite (SE) toothbrush
Number of subjects: 61
Study: 14991979

Group type: EXPERIMENTAL
Intervention: Inclined body positioning (45 degrees orthostasis) during artificial pulmonary ventilation
Number of subjects: 0
Study: 10489492

Group type: EXPERIMENTAL
Intervention: Mometasone furoate cream 0.1% applied once daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clobetasol propionate cream 0.05% applied twice daily
Number of subjects: 60
Study: 9156881

Group type: EXPERIMENTAL
Intervention: Doppler echocardiographic assessment of pulmonary artery flow parameters in patients with COPD
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (patients without COPD)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Doppler echocardiographic assessment of pulmonary artery flow parameters
Number of subjects: 50
Study: 1874210

Group type: EXPERIMENTAL
Intervention: Etomidate 1 mg kg‐1 followed by 1 mg kg‐1 h‐1
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propofol 2.5 mg kg‐1 followed by 9 mg kg‐1 h‐1
Number of subjects: 10
Study: 10994430

Group type: EXPERIMENTAL
Intervention: Armstrong ventilator tube with paracentesis and fluid aspiration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paracentesis and aspiration alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Armstrong tube
Number of subjects: 0
Study: 30714249

Group type: EXPERIMENTAL
Intervention: Opium tincture (OT)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 204
Study: 27881833

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 500

Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 500
Study: 27178570

Group type: EXPERIMENTAL
Intervention: Endoscopic group
Number of subjects: 63

Group type: COMPARATOR
Intervention: Open group
Number of subjects: 63
Study: 24914244

Group type: EXPERIMENTAL
Intervention: saxagliptin
Number of subjects: 16492

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16492
Study: 23241930

Group type: EXPERIMENTAL
Intervention: Meriva® (2 tablets/day, each containing 500 mg Meriva® corresponding to 100 mg curcumin) for at least 4 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard management plan alone
Number of subjects: 38